Literature DB >> 25511617

Association between seizures and outcomes among intracerebral hemorrhage patients: the China National Stroke Registry.

Zixiao Li1, Xingquan Zhao1, Yilong Wang1, Chunxue Wang2, Liping Liu2, Xiaoqiu Shao3, Wenjuan Wang4, Yuesong Pan2, Chunjuan Wang4, Ruijun Ji3, Changqing Zhang3, Jing Jing3, Yongjun Wang5.   

Abstract

BACKGROUND: To determine whether the presence of seizures in patients with spontaneous intracerebral hemorrhage (ICH) was associated with in-hospital complications and measured outcomes.
METHODS: This prospective cohort study from the China National Stroke Registry included consecutive patients with ICH between August 2007 and September 2008. In-hospital complications, functional outcomes, and mortality at 3, 6, and 12 months were compared between patients with seizures and those without seizures occurring at ICH onset and during hospitalization. Poor functional outcome was defined as a modified Rankin Scale score between 3 and 6. Poor functional outcome and mortality were stratified by stroke severity using Glasgow Coma Scale scores on admission.
RESULTS: The study included 3216 patients with ICH and 139 of them (4.3%) experienced seizures. The presence of seizures was associated with high in-hospital complications including atrial fibrillation (P = .004), pneumonia (P = .001), as well as lower rehabilitation assessment rates (P = .033) compared with patients without seizures. ICH patients with seizures had poorer functional outcome at 3-month (P = .012), 6-month (P = .007), and 12-month (P = .001) follow-up. They also had higher mortality at 3 months (P = .045), 6 months (P = .005), and 12 months (P = .002). Patients with mild strokes had poorer functional outcome and higher mortality (P < .005) if seizures occurred.
CONCLUSIONS: The presence of seizures in patients with ICH was associated with high in-hospital complications and indicates poor outcomes at 3-, 6-, and 12-month follow-up. Quality improvement strategies targeting ICH patients with seizures especially mild stroke may help improve prognoses.
Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intracerebral hemorrhage; all epilepsy/seizures; outcome research; risk factors

Mesh:

Year:  2014        PMID: 25511617     DOI: 10.1016/j.jstrokecerebrovasdis.2014.09.021

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Relationship Between Mortality and Seizures After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.

Authors:  Hong-Yu Lin; Qing-Qing Wei; Jian-Yi Huang; Xing-Hua Pan; Ning-Chao Liang; Cai-Xia Huang; Teng Long; Wen Gao; Sheng-Liang Shi
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

Review 2.  Association between seizures after ischemic stroke and stroke outcome: A systematic review and meta-analysis.

Authors:  Tao Xu; Shu Ou; Xi Liu; Xinyuan Yu; Jinxian Yuan; Hao Huang; Yangmei Chen
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  Chinese acute ischemic stroke treatment outcome registry (CASTOR): protocol for a prospective registry study on patterns of real-world treatment of acute ischemic stroke in China.

Authors:  Weiping Sun; Qianhua Ou; Zhijun Zhang; Jiazhi Qu; Yining Huang
Journal:  BMC Complement Altern Med       Date:  2017-07-06       Impact factor: 3.659

4.  Role of microRNA-155 in modifying neuroinflammation and γ-aminobutyric acid transporters in specific central regions after post-ischaemic seizures.

Authors:  Wenwen Zhang; Luping Wang; Xiaochuan Pang; Jian Zhang; Yi Guan
Journal:  J Cell Mol Med       Date:  2019-05-29       Impact factor: 5.310

5.  Discontinuation of preventive antiepileptic drugs in patients with intracerebral hemorrhage.

Authors:  Yi-Sin Wong; Chi-Shun Wu; Cheung-Ter Ong
Journal:  BMC Neurol       Date:  2021-04-07       Impact factor: 2.474

6.  Hospital-Level Variations in Rates of Inpatient Urinary Tract Infections in Stroke.

Authors:  Michelle Tørnes; David J McLernon; Max O Bachmann; Stanley D Musgrave; Elizabeth A Warburton; John F Potter; Phyo Kyaw Myint
Journal:  Front Neurol       Date:  2019-08-06       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.